Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Fluid Therapy × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Mantle-Cell 1 Leukemia, Myeloid, Acute 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1

Interventions

ruxolitinib 6 fludarabine 6 Specimen Handling 6 fludarabine phosphate 4 Whole-Body Irradiation 4 Cyclophosphamide 4 Biopsy 4 Azacitidine 4 venetoclax 3 decitabine and cedazuridine drug combination 3 Mycophenolic Acid 3 Melphalan 3 Cytarabine 3 Busulfan 3 Tacrolimus 2 Stem Cell Transplantation 2 Sirolimus 2 Liposomes 2 Injections 2 Granulocyte Colony-Stimulating Factor 2 Daunorubicin 2 CPX-351 2 selinexor 1 quizartinib 1 plerixafor 1 pegylated granulocyte colony-stimulating factor 1 olutasidenib 1 luspatercept 1 letermovir 1 iadademstat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡